LifeStance Health Group, Inc. (LFST)
USD 6.8
(4.29%)
USD 6.8
(4.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -104.92 Million USD | 24.28% |
| 2022 | -136.41 Million USD | 39.58% |
| 2021 | -229.62 Million USD | -602.76% |
| 2020 | 8.76 Million USD | 117.85% |
| 2019 | 21.33 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 5.88 Million USD | 173.18% |
| 2024 Q2 | 3.03 Million USD | -76.7% |
| 2023 Q1 | -15.06 Million USD | 44.6% |
| 2023 FY | - USD | 24.28% |
| 2023 Q4 | -9.07 Million USD | 83.43% |
| 2023 Q3 | -54.73 Million USD | -89.36% |
| 2023 Q2 | -28.9 Million USD | -91.83% |
| 2022 Q3 | -21.09 Million USD | 51.75% |
| 2022 Q2 | -43.72 Million USD | 11.06% |
| 2022 Q1 | -49.16 Million USD | 50.67% |
| 2022 FY | - USD | 39.58% |
| 2022 Q4 | -27.19 Million USD | -28.91% |
| 2021 Q1 | 9.41 Million USD | -37.71% |
| 2021 FY | - USD | -602.76% |
| 2021 Q4 | -99.67 Million USD | 10.94% |
| 2021 Q3 | -111.92 Million USD | -195.52% |
| 2021 Q2 | -37.87 Million USD | -502.18% |
| 2020 Q3 | 12.96 Million USD | 145.42% |
| 2020 Q2 | 5.28 Million USD | -26.75% |
| 2020 Q1 | 7.21 Million USD | 0.0% |
| 2020 FY | - USD | 117.85% |
| 2020 Q4 | 15.11 Million USD | 16.62% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 155.483% |
| Addus HomeCare Corporation | 106.55 Million USD | 198.468% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 470.606% |
| Amedisys, Inc. | 216.91 Million USD | 148.372% |
| Astrana Health, Inc. | 123.68 Million USD | 184.831% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 336.597% |
| IMAC Holdings, Inc. | -5.94 Million USD | -1664.413% |
| biote Corp. | 9.23 Million USD | 1236.301% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -907.229% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 181.127% |
| COMPASS Pathways plc | -123.8 Million USD | 15.247% |
| DocGo Inc. | 32.72 Million USD | 420.628% |
| The Ensign Group, Inc. | 353.23 Million USD | 129.704% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 239.507% |
| InnovAge Holding Corp. | 1.15 Million USD | 9192.374% |
| The Joint Corp. | 9.14 Million USD | 1247.771% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -574.563% |
| ModivCare Inc. | -26.75 Million USD | -292.247% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 27402.793% |
| Option Care Health, Inc. | 376.79 Million USD | 127.847% |
| P3 Health Partners Inc. | -81.07 Million USD | -29.425% |
| P3 Health Partners Inc. | -81.07 Million USD | -29.425% |
| The Pennant Group, Inc. | 30.36 Million USD | 445.504% |
| Surgery Partners, Inc. | 446.1 Million USD | 123.521% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -3599.937% |
| Talkspace, Inc. | -22.01 Million USD | -376.655% |
| Talkspace, Inc. | -22.01 Million USD | -376.655% |
| The Oncology Institute, Inc. | -70.45 Million USD | -48.928% |
| The Oncology Institute, Inc. | -70.45 Million USD | -48.928% |